Pfizer Ibrance and Astrazeneca Faslodex slows Progression of Breast Cancer together
The latest targeted drug from the pharmaceutical giant Pfizer, ‘palbociclib’ has been able to stop the progression of the most common form of advanced breast cancer. This was reported by researchers on Saturday...